Evidence map›Paper›PMID 31739586›Full record

ReviewViruses2019

Relating GPI-Anchored Ly6 Proteins uPAR and CD59 to Viral Infection.

Jingyou Yu, Vaibhav Murthy, Shan-Lu Liu

Open access · goldAbstract readReview
In one paragraph

Review in Viruses, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Current status and prospects of genetically modified porcine-to-human cardiac xenotransplantation.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. The myxozoansFrontiers in cellular and infection microbiology · 2024
    Article
  13. Article
  14. Multiple CD59 Polymorphisms in Chinese Patients withJournal of immunology research · 2023
    Article
  15. Article
  16. Review
  17. Phospholipase A2 inhibitor and LY6/PLAUR domain-containing protein PINLYP regulates type I interferon innate immunity.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jingyou YuCenter for Retrovirus Research, The Ohio State University, Columbus, OH 43210, USA.
Vaibhav MurthyCenter for Retrovirus Research, The Ohio State University, Columbus, OH 43210, USA.
Shan-Lu LiuCenter for Retrovirus Research, The Ohio State University, Columbus, OH 43210, USA.
The Ohio State University · US

Funding

NIH HHS AI112381NIH HHS AI150473
6 · The paper itself

Abstract

The Ly6 (lymphocyte antigen-6)/uPAR (urokinase-type plasminogen activator receptor) superfamily protein is a group of molecules that share limited sequence homology but conserved three-fingered structures. Despite diverse cellular functions, such as in regulating host immunity, cell adhesion, and migration, the physiological roles of these factors

Indexed as

Host-Pathogen InteractionsBiosynthetic PathwaysCD59 AntigensCytokinesHumansMultigene FamilyReceptors, Urokinase Plasminogen ActivatorStructure-Activity RelationshipVirus DiseasesCD59 AntigensCD59 protein, humanCytokinesReceptors, Urokinase Plasminogen ActivatorCD59Ly6ELy6/uPARuPAR/CD87viruses

Identifiers

PMID31739586
PMCPMC6893729
OpenAlexW2985415435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.